Fluorescent collagen hybridizing peptide for quantifying collagen denaturation in cortical bone

William Woolley1, Naomi Chin1, S Michael Yu2

  • 1Department of Mechanical and Aerospace Engineering, University of California San Diego, La Jolla 92093, CA, USA.

Bone Reports
|July 18, 2025
PubMed
Summary

Bone fracture risk assessment needs better tools beyond bone mineral density (BMD). This study introduces Collagen Hybridizing Peptide (CHP) to quantify denatured collagen, a key factor in bone quality and fracture risk.

Related Concept Videos